1. APF530 (Granisetron Injection Extended-Release) in a Three-Drug Regimen for Delayed CINV in Highly Emetogenic Chemotherapy
   Ian D Schnadig et al, 2016, Future Oncology CrossRef
2. The Significance of NK1 Receptor Ligands and Their Application in Targeted Radionuclide Tumour Therapy
   Agnieszka Majkowska-Pilip et al, 2019, Pharmaceutics CrossRef
3. Efficacy of 3-day versus 5-day aprepitant regimens for long-delayed chemotherapy-induced nausea and vomiting in patients receiving cisplatin-based chemotherapy
   Toshinobu Hayashi et al, 2023, Expert Opinion on Pharmacotherapy CrossRef
4. Neutropenic sepsis rates in patients receiving bleomycin, etoposide and cisplatin chemotherapy using olanzapine and reduced doses of dexamethasone compared to a standard antiemetic regimen
   Ernese Gjafa et al, 2021, BJU International CrossRef
5. Comparison between 5-day aprepitant and single-dose fosaprepitant meglumine for preventing nausea and vomiting induced by cisplatin-based chemotherapy
   Yosuke Ando et al, 2016, Supportive Care in Cancer CrossRef